Llergan Inc. Voluntarily Withdraws Its Drug Fibristal, Used To Treat Uterine Fibroids, From The Canadian Marke
Recall Summary Allergan Inc. is withdrawing Fibristal, a medication used to treat uterine fibroids, from the Canadian market. The recall affects all patients currently using or prescribed this drug across Canada. No specific reason for the withdrawal was provided in the notice.
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2020-09-30
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/c63d2b1c-a18d-4576-89bd-123021e9150e